Related Experiment Videos
Endothelin-1 in heart failure: a new therapeutic target?
1Department of Cardiac Medicine, National Heart and Lung Institute, London, UK.
Lancet (London, England)
|August 17, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Resolution of central sleep apnoea following implantation of a left ventricular assist device.
International journal of cardiology·2008
A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction.
European journal of heart failure·2006
ESC-CHF: guidelines for the aspirational and the practical.
Heart (British Cardiac Society)·2006
Can heart rate variation rule out sleep-disordered breathing in heart failure?
The European respiratory journal·2006
Diuretics for heart failure.
The Cochrane database of systematic reviews·2006
Risk of transmission of amyloid β pathology via transfused blood products.
Lancet (London, England)·2026
Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.
Rheumatology (Oxford, England)·2026
Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.
The British journal of radiology·2026
One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.
Molecular medicine reports·2026